Chinese instructions for Sotagliflozin

1. Indications:

Sogliflozin is suitable for the treatment of type 2 diabetes. It can be considered as an auxiliary treatment option especially when patients have poor response to other oral hypoglycemic drugs or have cardiovascular risks.

2. Mechanism of action:

Sogliflozin is an SGLT1/2 inhibitor that achieves dual inhibitory effects by acting on glucose transporters in the intestine and renal tubules simultaneously. SGLT1Mainly distributed in the small intestine, responsible for the absorption of glucose from food; SGLT2Mainly present in the renal tubules, involved in the reabsorption of glucose in urine. Soxgliflozin reduces blood sugar levels by inhibiting these two transporters, slowing the absorption of glucose from food while increasing the excretion of glucose in the urine.

3. Pharmacology:

1.Glycemic regulation: Soxgliflozin helps improve blood sugar control by slowing intestinal absorption of glucose and causing excess glucose to be excreted in the urine.

2.Cardiovascular protection: Research shows that soxgliflozin has a positive impact on the cardiovascular system, reducing the risk of cardiovascular events, including cardiovascular death, myocardial infarction and stroke.

3.Renal protection: Sogliflozin may have a protective effect on renal function by reducing urinary protein excretion and regulating glomerular hemodynamics.

4. Dosage and usage:

1.Recommended dosage: Generally, take it orally once a day. The specific dosage needs to be adjusted according to the patient's diabetes status and individual response, and is personalized by the doctor.

2.Usage: It can be taken with meals or on an empty stomach. It is recommended that patients take it on time and in the right amount under the guidance of a doctor.

5. Side effects:

1.Urinary tract infection: The study found that some patients may have symptoms of urinary tract infection, such as frequent urination, urgency, etc.

2.Acidosis: In rare cases, there is a risk of metabolic acidosis, and patients should be closely monitored for symptoms.

3.Hypoglycemia: Especially when used in combination with insulin or other antidiabetic drugs, there is a risk of hypoglycemia.

6. Warnings and precautions:

1.Renal function monitoring: Patients should regularly monitor renal function and urinary protein excretion while using soxgliflozin, especially for patients with underlying renal disease.

2.Cardiovascular risk: Patients need to be alert to whether there is a risk of cardiovascular disease when using soxgliflozin, and doctors should consider it comprehensively in patient assessment.

3.Special groups: Use with caution in elderly patients, children, pregnant women and lactating women, and under the advice of a doctor.

7. Contraindications:

Patients who are allergic to soxgliflozin or any ingredient in the medicine.

Patients with severe renal insufficiency.

8. Drug interactions:

1.Insulin and other antidiabetic drugs: Using these drugs together may increase the risk of hypoglycemia.

2.Diuretics: Drugs have a diuretic effect, and combined use with diuretics may increase the risk of dehydration and hypovolemia.

9. Medication for special groups:

1.Elderly patients: Use with caution. Doctors should adjust the dosage according to the patient's overall condition and renal function.

2.Pregnant and lactating women: It should be used under the supervision of a doctor, and the benefits and potential risks of the drug should be weighed.

Sogliflozin, as an SGLT1/2 inhibitor, shows potential advantages in the treatment of diabetes, especially in terms of renal and cardiovascular protection. However, patients should fully understand the indications, usage and dosage, possible side effects and precautions before use, and use it under the guidance of a doctor to ensure safe and effective treatment. This instruction manual is not a document that replaces the advice of a professional doctor. Patients should consult their doctor before using soxgliflozin to obtain personalized medical advice.